Effects of a pain consult and patient education and monitoring: a prospective study in oncology patients

ISRCTN ISRCTN68236655
DOI https://doi.org/10.1186/ISRCTN68236655
Secondary identifying numbers NTR613; EMC 2005 - 257
Submission date
28/04/2006
Registration date
28/04/2006
Last edited
10/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr W.H. Oldenmenger
Scientific

Erasmus Medical Center
Daniel den Hoed Cancer Center
P.O. Box 5201
Rotterdam
3008 AE
Netherlands

Phone +31 (0)10 4391439
Email w.h.oldenmenger@erasmusmc.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesIt is hypothesised that a pain consult at the specialized pain clinic in combination with Patient Education Program is more effective in reducing average pain intensity compared to a pain consult alone. A pain consult at the specialized pain clinic is more effective in reducing average pain intensity compared to standard care.
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedCancer pain
Intervention1. Standard care
2. Second opinion pain consult at the specialist pain clinic
3. Second opinion pain consult combined with Pain Education Program and monitoring by nurse specialists
Intervention typeOther
Primary outcome measureAverage pain reduction measured by numeric rating scale during the study period.
Secondary outcome measuresEffect of the interventions after 2, 4 and 8 weeks on:
1. Adherence to ATC analgesics
2. Worst pain reduction
3. Average pain reduction
4. Present pain reduction
5. Proportion of patients with clinically relevant pain reduction
6. Pain interference
7. Quality of life
8. Reduction of side effects
9. Adequacy of pain treatment
10. Pain knowledge
Overall study start date01/02/2006
Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants165
Key inclusion criteria1. Cancer-related pain or cancer treatment related pain for at least two weeks
2. Nociceptive pain
3. Average pain intensity score of 4 or more
4. Accessibility by telephone
5. A life expectancy of at least three months
6. Informed consent
Key exclusion criteria1. Neuropathic pain
2. Residing in nursing home or retirement home
3. Pain not treated with oral medication
4. Radiotherapy in the past two weeks
Date of first enrolment01/02/2006
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Erasmus Medical Center
Rotterdam
3008 AE
Netherlands

Sponsor information

Erasmus Medical Center (Netherlands)
University/education

P.O. Box 2040
Rotterdam
3000 CA
Netherlands

ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

University/education

Erasmus Medical Center (Netherlands)
Government organisation / Universities (academic only)
Alternative name(s)
Erasmus Medical Center, Erasmus MC, Erasmus Universitair Medisch Centrum, Erasmus University Medical Center, Universitair Medisch Centrum Rotterdam, Erasmus Universitair Medisch Centrum Rotterdam, EMC
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan